Atopic Dermatitis Upadacitinib Beats Dupilumab Across All Ranked Secondary End Points in AD Study: Dr. Jonathan Silverberg Reviews the Data
Headlines in Dermatology Melanoma Monday 2024: Advances in the Early Detection and Treatment of Melanoma Are Changing the Game